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muscle cells. It has been argued that the levels of IL-6 receptors expressed by human myotubes are not sufficient to mediate IL-6 signaling or that subsequently the sensitivity of myotubes to respond to IL-6 is markedly low compared with other cells, e.g. hepatocytes (18, 21) .
The aim of the present study was to investigate the effects of glucose, insulin and circulating free fatty acids on IL-6 gene expression and protein secretion in skeletal muscle cells. These metabolic factors are increased in obese, insulin resistant individuals and skeletal muscle is the tissue mainly responsible for peripheral insulin resistance. Furthermore, we studied the expression of IL-6 receptor components gp 130 and IL-6R and investigated the sensitivity of human myotubes to IL-6 by examining the concentration-dependent effect of IL-6 on STAT-3 tyrosine phosphorylation. We demonstrate that specifically saturated FFA, e.g. palmitate, induce IL-6 mRNA expression and protein secretion by a proteasome-dependent mechanism, leading to IkB-a degradation and NF-kB activation. Insulin, high glucose concentrations or unsaturated FFA did not activate IL-6 expression. In fact, the unsaturated FFA linoleate inhibited palmitate-induced IL-6 production. Furthermore, we show that in human myotubes IL-6 activates the janus kinase-signal transducer and activator of transcription (JAK-STAT) pathway in concentrations similar to hepatocytes, however, no inhibitory effect of IL-6 on insulin action, determined as PI 3-kinase association with insulin receptor substrate-1 (IRS), Akt phosphorylation and glycogen synthesis, was detected. Western blotting. Cells were lysed with 600 ml of lysis buffer/10cm-dish (50 mM Tris pH 7.6, 150 mM NaCl, 1% Triton X-100, containing protease and phosphatase inhibitors). Cytosolic extracts of myotubes or immunoprecipitated proteins were separated by sodium dodecyl sulfate polyacrylamide (7.5 %) gel electrophoresis. Proteins were transferred to nitrocellulose by semi-dry-electroblotting (transfer buffer: 48 mM Tris, 39 mM glycine, 0.0375 % sodium dodecyl sulfate, 20 % (v/v) methanol). Then nitrocellulose membranes were blocked with NET buffer (150 mM NaCl, 50 mM Tris/HCl pH 7.4, 5 mM EDTA, 0.05 % Triton X-100, 0.25 % gelatine) and incubated with the first antibody (diluted 1:1000 in NET) overnight at 4 °C. After washing with NET buffer the membranes were incubated with horseradish peroxidase-conjugated anti-rabbit or anti-mouse IgG for 1 h at room temperature.
Electrophoretic mobility shift assay. Nuclear proteins were prepared as described recently (24 Glycogen synthesis. Glycogen synthesis was assayed as described in (22) with modifications.
Fused myotubes in 6-well plates were pretreated for 90 min with IL-6 (20 ng/ml) in serumfree a-MEM containing 5.5 mM glucose. Cells were then incubated with 10 or 100 nM insulin for 30 min prior to addition of D-glucose/D-[U-14 C]glucose (10 mM final concentration, 0.3 mCi/well). After 60 min at 37°C, the supernatants were aspirated, and the cells were washed 3 times with ice-cold PBS and lysed in 300 ml 30 % KOH. Aliquots (10 ml/well) were removed for determination of protein content. The extracts were heated for 30 min at 95 °C and glycogen (2 mg/ml final concentration) was added as carrier. Glycogen was precipitated with 550 ml 95 % ethanol and collected by centrifugation for 10 min at 10000 g. The glycogen pellet was resuspended in 500 ml water, and counted by liquid scintillation counting.
Glycogen synthesis was expressed as cpm/well/mg of protein.
Statistical analysis.
Results presented are derived from at least three independent experiments. Means ± SEM were calculated and groups of data were compared using student´s t test. Statistical significance was set at P < 0.05. 
Results

Activation of IL-6 mRNA expression by saturated fatty acids in human myotubes
First we studied if metabolic parameters such as insulin or high glucose concentrations affect the expression of IL-6 in human myotubes. High glucose concentrations (30 mM) showed no effect on IL-6 mRNA expression after a 48 h incubation period, either alone or in combination with 10 or 100 nM insulin and 100 nM insulin alone even reduced IL-6 mRNA expression levels by 30 % (Fig. 1A) . Since we have recently observed that 0.5 mM of saturated fatty acids up-regulates glutamine:fructose-6-phosphate-aminotransferase expression in human myotubes after 20 h (26) we used this experimental condition to evaluate the effect of different FFAs on IL-6 expression. As shown in Figure 1B , stimulation of myotubes with 0.5 mM palmitate or stearate for 20 h resulted in a significant increase in IL-6 mRNA expression. The effect of unsaturated FFA palmitoleate, oleate and linoleate was similar to the effect observed in control cells treated with BSA (fatty acid free) alone.
Incubation with FFAs had no effect on cell number or DNA content (data not shown). Since the plasma concentration of FFA is < 0.7 mM in the postabsorptive state and might rise to >1 mM after a fatty meal or during fasting and since palmitate is the most abundant saturated FFA in plasma (palmitate 20-35%, stearate ca. 10%) the effect of palmitate was studied in more detail. When we examined the effect of increasing concentrations of palmitate on IL-6 mRNA expression we found no effect with 0.125 mM palmitate but a maximal stimulation with 0.25 mM palmitate (data not shown). Therefore, we used this concentration for further studies. Since TNF-a is a known strong inducer of IL-6 we compared the effect of palmitate and TNF-a on IL-6 expression in human myotubes. As shown in Figure 1C 0.25 mM palmitate induced IL-6 mRNA to a similar extend as TNF-a. We observed also a small effect of FFA-free BSA which was used as carrier for FFA (1.4-fold) . In further studies we corrected all FFA effects to the FFA-free BSA control.
Time-dependent increase in cellular IL-6 mRNA levels and IL-6 protein production in palmitate-treated myotubes Next, we studied the time response of palmitate-induced IL-6 mRNA and protein expression.
After 1 h of incubation with 0.25 mM palmitate an increased IL-6 mRNA level was detected, which was not further enhanced during the next 7 h of palmitate stimulation (1.5 -2.0-fold; Fig. 2A ). The increase in IL-6 mRNA levels peaked after 24 h (5-fold; Fig. 2A ) and remained elevated after 48 h. To assess whether the palmitate-induced increase in IL-6 mRNA expression was translated into an enhanced IL-6 protein production and subsequent secretion Il-6 protein content in cellular supernatants was determined by ELISA. As shown in Fig. 2B palmitate induced a significant increase in IL-6 protein production as early as after 1 h which increased with time. After 24 h 3.0 ± 0.3 ng/mg DNA were produced and secreted into the supernatant and after 48 h 5.7 ± 1.4 ng/mg DNA were accumulated. The data indicates that the rapid increase in IL-6 mRNA is readily translated into IL-6 protein and that the increases in IL-6 protein production remain high after 24 and 48 h as suggested by the high cellular IL-6 mRNA levels at these time points (Fig. 2A) .
The induction by palmitate is proteasome-dependent and does not require metabolism to acyl-CoA
Since the transcription factor NF-kB has been shown to be involved in activation of IL-6 gene expression in various tissues and cells (27-29), we tested the possibility of NF-kB mediating the palmitate-induced IL-6 expression in human myotubes. The activation of NF-kB requires proteasome activity (30, 31) and can be enhanced by oxidative stress (32) . To elucidate whether proteasome activity or oxidative stress is induced by palmitate and mediates the upregulation of IL-6 mRNA expression inhibition experiments were performed. Activation of myotubes with 0.25 mM palmitate in the presence of 0.5 mM of the anti-oxidant a-lipoic acid did not prevent IL-6 mRNA induction (Fig. 3A) . Similarly, preincubation with 0.1 mM alipoic acid for 48 h, which was shown to prevent oxidative stress-mediated activation of NFkB (33), failed to inhibit IL-6 mRNA expression (Fig. 3A) . However, presence of the proteasome inhibitor MG 132 (10 mM) completely blocked palmitate-induced IL-6 expression ( Fig. 3A,B) . Thus, activation of NF-kB by a proteasome-dependent pathway could be involved in IL-6 upregulation by palmitate.
Palmitate has been linked to the activation of several signaling pathways, e.g. via its metabolism to diacylyglycerol and subsequent activation of protein kinase C (34, 35) , by palmitoylation of proteins (36), or by conversion to ceramide (37) . All these events require activation of palmitate to palmitoyl-CoA by acyl-CoA synthetase. Therefore we studied whether this conversion is required for the effect on IL-6 expression. In the presence of triacsin C, an inhibitor of acyl-CoA synthetase (38) , no reduction of IL-6 mRNA expression was detected (Fig. 3C) ; in contrast the effect of palmitate on IL-6 mRNA expression was almost doubled (8.3 ± 0.9 vs. 4.7 ± 0.3). Moreover, we observed that in the presence of equal amounts of linoleate and palmitate, the palmitate-induced upregulation of IL-6 was prevented (Fig. 3C ). Furthermore, our observation that myriocin and cycloserine, both inhibitors of ceramide biosynthesis, had no effect on palmitate-induced IL-6 expression further supports the view that activation of palmitate to palmitoyl-CoA is not necessary for the observed palmitate effect (Fig. 3D ).
The inhibitory action of MG 132 and linoleate was also found on palmitate-induced IL-6 protein production (Fig. 3E) . In accordance to the data obtained on mRNA level, a-lipoic acid had no effect on enhanced IL-6 protein production (Fig. 3E ). In the presence of the acyl-CoA synthetase inhibitor triacsin C IL-6 protein induction was not prevented (Fig. 3E) . Thus, unmetabolized, nonesterified palmitate is the responsible signaling molecule leading to IL-6 mRNA and protein expression.
Palmitate activates NF-kB
Since inhibition of proteasome activity with MG 132 blocked IL-6 mRNA induction completely and since activation of the transcription factor NF-kB requires proteasomedependent degradation of IkB-a   we investigated the hypothesis that stimulation of myotubes with palmitate resulted in activation of NF-kB. Using electrophoretic mobility shift assays we performed. We observed p65 to be the major component of the NF-kB complex (Fig. 4C , lanes 5-7) and anti-p50 antibodies also attenuated the NF-kB binding, clearly detectable in nuclear extracts obtained after 20 h of palmitate treatment (Fig. 4C, lanes 8-10) .
The key to NF-kB regulation is the inhibitory kB (IkB) proteins which retain NF-kB in the cytoplasm. Phosphorylation of IkB-a by IkB kinases triggers its polyubiquitinylation and degradation, thereby releasing NF-kB which translocates to the nucleus (30, 31) . Therefore, we investigated the molecular mechanism of palmitate-induced NF-kB activation by studying the amount of IkB-a and its serine-32 phosphorylation in palmitate-treated myotubes.
Immunoblots using anti-IkB-a-antibodies revealed a reduction of IkB-a protein as early as after 1 h of palmitate-stimulation and it remained reduced after 4 and 20 h of palmitatetreatment well in line with the kinetic of activated DNA binding activity of NF-kB (Fig. 4D) .
In contrast, IkB-b protein levels were unchanged (Fig.4D ). In immunoblots with antiphospho-ser32-antibodies a large increase in phosphorylation of IkB-a on serine 32 was detected after 30 min of palmitate-treatment, while later on the phosphorylation decreased to basal levels (Fig. 4E ). Thus, a rapid, palmitate-induced phosphorylation of IkB-a  is the signal for the proteasome-dependent degradation of this protein, thereby leading to translocation to the nucleus, binding to consensus sequences and subsequently to IL-6 mRNA expression.
IL-6 signaling in human myotubes
Since we could clearly demonstrate that human myotubes express and secrete relevant amounts of IL-6, we studied the putative auto/paracrine effect of IL-6. IL-6 signaling requires the expression of receptors gp130 and the IL-6 receptor (IL-6R), acting as heterodimer in the binding and signal transduction of IL-6 (39). Using real-time PCR, we found that both receptors were expressed in human myotubes and that the expression was not affected by palmitate or linoleate (Fig. 5A,B) . min activated phosphorylation of STAT-3, while supernatant of untreated control cells had no effect (Fig. 5D ). Moreover, this activation is IL-6-dependent, since addition of neutralizing IL-6 antibodies clearly reduced STAT-3 phosphorylation (Fig. 5D) . Thus, palmitate-induced IL-6 production mediates activation of IL-6 signaling pathways in myotubes.
Effect of IL-6 on insulin signaling in myotubes
Increases in circulating IL-6 plasma levels have been associated with insulin resistance in humans (11-14) and IL-6 has been demonstrated to reduce insulin-stimulated signaling in 20 ng/ml IL-6 for 90 min, which had been shown to exhibit a maximum reduction of insulinstimulated p85/IRS-1 complex formation in hepatocytes (19) , had no inhibitory effect on p85/IRS-1 association in myotubes. Accordingly, insulin-stimulated phosphorylation of serine 473 of Akt, was not attenuated in the myotubes after IL-6 preincubation, while IL-6 alone induced a weak phosphorylation of Akt (Fig. 6B) . Similarly, insulin-induced glycogen synthesis was not reduced by IL-6 (2.23 ± 0.17-fold after stimulation with 100 nM insulin and preincubation with IL-6 compared to 2.31 ± 0.13-fold with insulin alone, Fig. 6C ). When myotubes were treated with 10 nM insulin, we observed even a stimulatory effect of IL-6 on glycogen synthesis (2.28 ± 0.18 and 1.49 ± 0.06, respectively; Fig. 6C ). Since both cell types, hepatocytes and myotubes, were sensitive to similar insulin concentrations and the IL-6
concentrations necessary for STAT-3 phosphorylation were comparable, we conclude that in human myotubes IL-6 is not a mediator of cellular insulin resistance.
In contrast, fatty acids, e.g. palmitate (35, 40, 41) have been shown to inhibit insulin action in skeletal muscle. In line with these reports, pretreatment of our myotubes with 0.5 mM palmitate for 20 h attenuated the glycogen synthesis stimulated with 100 nM insulin to 80 % (1.68 ± 0.08 compared to 2.09 ± 0.14, respectively; data not shown). However, from our results it seems unlikely that IL-6 is the mediator of fatty acid-induced insulin resistence in skeletal muscle cells.
Discussion
In the present study we demonstrate that saturated FFA, in contrast to unsaturated FFA, high glucose concentrations or insulin, activate gene expression and protein production of IL-6 in human myotubes. The induction occurs rapidly within 1 h and is maintained during the next 48 h. We found also a small but significant effect of FFA free BSA alone on IL-6 gene expression. We suggest that a contamination with low endotoxin amounts in the BSA preparation accounts for this induction of IL-6 since NF-kB activity, known to be readily induced by endotoxins (42) , is slightly enhanced in BSA-treated myotubes. The novel finding that saturated FFA induce IL-6 expression is striking since the current view is that IL-6 expression is regulated by mediators of the pro-and anti-inflammatory network. We focused in our study on palmitate, since a maximum effect was achieved with 0.25 mM palmitate, a plasma concentration which is also present in the postprandial state and during fasting. While the presence of unsaturated fatty acids alone did not enhance IL-6 mRNA levels, coincubation of myotubes with equimolar concentrations of linoleate and palmitate completely prevent the stimulatory action of the saturated FFA. A protective effect of unsaturated FFA on palmitatemediated lipotoxicity has also been described recently for pancreatic b-cell apoptosis (43, 44) .
In this report it could be demonstrated that excess palmitate is poorly incorporated into triglyceride and causes apoptosis (43) . Unsaturated FFA promote channeling of palmitate into triglyceride pools away from pathways leading to apoptosis. Thus stimulation of palmitate metabolism to triglycerides would also be an possible explanation for the inhibitory effect of linoleate in our experiments.
Further support for this hypothesis is provided by our results demonstrating that the free, non- Following this line, we investigated the effect of IL-6 on insulin signaling. IL-6 has been shown to impair insulin signaling in hepatocytes and HepG2 cells (19, 20) and to mediate liver insulin resistance in vivo as demonstrated after chronic IL-6 administration in mice (18) .
However, using similar experimental conditions as in the studies performed with HepG2 cells and hepatocytes we observed no inhibitory effect of IL-6 on insulin-stimulated PI 3 kinase p85 subunit/IRS-1 complex formation and on insulin-stimulated serine 473 phosphorylation of Akt. Activation of PI 3 kinase and Akt are key events in insulin signaling in skeletal muscle necessary for insulin stimulation of both, glucose transport and glycogen synthesis.
Accordingly, insulin-induced glycogen synthesis was not reduced by IL-6 in the myotubes.
Thus, we conclude that IL-6 is unlikely to be a mediator of cellular insulin resistance in skeletal muscle cells. A recent study shows that a 5-day infusion of IL-6 failed to reduce skeletal muscle insulin receptor signaling in mice (18) which is well in line with our observation. production of the skeletal muscle in remains to be determined.
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